Copyright
©The Author(s) 2021.
World J Clin Oncol. May 24, 2021; 12(5): 290-308
Published online May 24, 2021. doi: 10.5306/wjco.v12.i5.290
Published online May 24, 2021. doi: 10.5306/wjco.v12.i5.290
Figure 1 Treatment modalities available for unresectable (advanced) hepatocellular carcinoma, which is non-amendable to loco-regional therapies.
CAR: Chimeric antigen receptor; HCC: Hepatocellular carcinoma; TCR: T cell receptor; VEGF: Vascular endothelial growth factor.
- Citation: Damiris K, Abbad H, Pyrsopoulos N. Cellular based treatment modalities for unresectable hepatocellular carcinoma. World J Clin Oncol 2021; 12(5): 290-308
- URL: https://www.wjgnet.com/2218-4333/full/v12/i5/290.htm
- DOI: https://dx.doi.org/10.5306/wjco.v12.i5.290